The UK’s 2026 Clinical Trial Regulations: A Strategic Analysis for Global Pharmaceutical Sponsors
Crossref DOI link: https://doi.org/10.1007/s43441-026-00931-1
Published Online: 2026-02-27
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Alghabban, Amer
Text and Data Mining valid from 2026-02-27
Version of Record valid from 2026-02-27
Article History
Received: 2 October 2025
Accepted: 25 January 2026
First Online: 27 February 2026
Declarations
:
: The authors declare no competing interests.